Intravenous immunoglobulin for immunomodulation of systemic lupus erythematosus

Autoimmunity Reviews

Volumn 5, Issue 2 SPEC. ISS., 2006, Pages 153-155

  Sherer, Yaniv ^a   Shoenfeld, Yehuda ^a,b  

^a TEL AVIV UNIVERSITY   (Israel)

^b SHEBA MEDICAL CENTER   (Israel)

Author keywords

Immunomodulation; Intravenous immunoglobulin; Systemic lupus erythematosus

Indexed keywords

CORTICOSTEROID; CYCLOPHOSPHAMIDE; IMMUNOGLOBULIN; PREDNISONE;

CONFERENCE PAPER; DISEASE COURSE; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFICACY; HUMAN; IMMUNOMODULATION; IMMUNOTHERAPY; LUPUS ERYTHEMATOSUS NEPHRITIS; SALVAGE THERAPY; SUBSTITUTION THERAPY; SYSTEMIC LUPUS ERYTHEMATOSUS; TREATMENT OUTCOME;

EID: 31144472862     PISSN: 15689972     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.autrev.2005.09.002     Document Type: Conference Paper

References (12)

1. E. Toubi, A. Kessel, and Y. Shoenfeld High-dose intravenous immunoglobulins: an option in the treatment of systemic lupus erythematosus Hum Immunol 66 2005 395 402
2. Y. Sherer, Y. Levy, P. Langevitz, M. Lorber, F. Fabrizzi, and Y. Shoenfeld Successful treatment of systemic lupus erythematosus cerebritis with intravenous immunoglobulin Clin Rheumatol 18 1999 170 173
3. Y. Sherer, Y. Levy, and Y. Shoenfeld Marked improvement of severe cardiac dysfunction after one course of intravenous immunoglobulin in a patient with systemic lupus erythematosus Clin Rheumatol 18 1999 238 240
4. Y. Sherer, P. Langevitz, Y. Levy, F. Fabrizzi, and Y. Shoenfeld Treatment of chronic bilateral pleural effusions with intravenous immunoglobulin and cyclosporin Lupus 8 1999 324 327
5. M. Meissner, Y. Sherer, Y. Levy, H. Chwalinska-Sadowska, P. Langevitz, and Y. Shoenfeld Intravenous immunoglobulin therapy in a patient with lupus serositis and nephritis Rheumatol Int 19 2000 199 201
6. Y. Levy, Y. Sherer, A. Ahmed, P. Langevitz, J. George, and F. Fabbrizzi A study of 20 SLE patients with intravenous immunoglobulin - clinical and serologic response Lupus 8 1999 705 712
7. M. Goodfield, K. Davison, and K. Bowden Intravenous immunoglobulin (IVIg) for therapy-resistant cutaneous lupus erythematosus J Dermatolog Treat 14 2004 46 50
8. Y. Sherer, Y. Levy, P. Langevitz, L. Rauova, F. Fabrizzi, and Y. Shoenfeld Adverse effects of intravenous immunoglobulin therapy in 56 patients with autoimmune diseases Pharmacology 62 2001 133 137
9. J.N. Boletis, J.P. Ioannidis, K.A. Boki, and H.M. Moutsopoulos Intravenous immunoglobulin compared with cyclophosphamide for proliferative lupus nephritis Lancet 354 1999 569 570
10. Y. Levy, Y. Sherer, J. George, J. Rovensky, J. Lukac, and L. Rauova Intravenous immunoglobulin treatment of lupus nephritis Semin Arthritis Rheum 29 2000 321 327
11. D. Monova, N. Belovezhdov, I. Altunkova, and S. Monov Intravenous immunoglobulin G in the treatment of patients with chronic glomerulonephritis: clinical experience lasting 15 years Nephron 90 2002 262 266
12. Y. Shoenfeld, L. Rauova, B. Gilburd, F. Kvapil, I. Goldberg, and J. Kopolovic Efficacy of IVIG affinity-purified anti-double-stranded DNA anti-idiotypic antibodies in the treatment of an experimental murine model of systemic lupus erythematosus Int Immunol 14 2002 1303 1311